A*STAR Bioprocessing Technology Institute (A*STAR BTI)

An optimized technique allows B cells to be transfected with extraneous DNA without the use of viruses

Magnetic nanoparticles break the capacity barrier for antibody purification

A library of sequences that modify relative gene expression enables tighter control over protein production

Mammalian cells have been engineered to produce longer-lived versions of the therapeutic protein erythropoietin

A novel targeted mass spectrometry technique uncovers an elusive sugar modification in stem cells

A regulatory protein called HEXIM1 induces human pluripotent stem cells to adopt a more specialized cell fate

A protein called FAIM could help doctors to parse which cancer patients will respond to multiple myeloma therapy

Breakthrough technology quickly separates large proteins and viruses from their surroundings, which improves purification of vaccines and protein therapuetics

Insights into cellular productivity could boost generation of proteins with valuable research and medical applications

Inducing stem cells to become different cell types efficiently, and on a large scale, is now possible using a three-dimensional platform

Researchers from A*STAR explain how defects in a signaling protein sabotage the immune system in multiple, seemingly contradictory ways

A single enzyme plays a critical role in helping the body effectively fight viral infection